Hepatitis Monthly

Published by: Kowsar

Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non- Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study

Ali Akbar Hajiaghamohammadi 1 , Amir Ziaee 1 , Sonia Oveisi 1 , * and Homa Masroor 1
Authors Information
1 Metabolic Disease Research Center, Qazvin University of Medical Science, soveisi@razi.tums.ac.ir, IR Iran
Article information
  • Hepatitis Monthly: 12 (8); 1-6
  • Published Online: September 3, 2012
  • Article Type: Research Article
  • Received: May 12, 2012
  • Accepted: July 11, 2012
  • DOI: 10.5812/hepatmon.6099

To Cite: Hajiaghamohammadi A A, Ziaee A, Oveisi S, Masroor H . Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non- Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study, Hepat Mon. Online ahead of Print ; 12(8):6099. doi: 10.5812/hepatmon.6099.

Abstract
© 2012, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments